UCN-01-mediated G1 arrest in normal but not tumor breast cells is pRb-dependent and p53-independent

Oncogene

Volumn 18, Issue 41, 1999, Pages 5691-5702

  Chen, Xiaomei ^a   Lowe, Michael ^a   Keyomarsi, Khandan ^a,b  

^a WADSWORTH CENTER   (United States)

^b STATE UNIVERSITY OF NEW YORK   (United States)

Author keywords

Cell cycle; E6; E7; p53; pRb; UCN 01

Indexed keywords

7 HYDROXYSTAUROSPORINE; PROTEIN P27; PROTEIN P53;

ARTICLE; BREAST CANCER; BREAST EPITHELIUM; CANCER CELL CULTURE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE S PHASE; CELL GROWTH; CONTROLLED STUDY; DRUG EFFECT; GROWTH INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

EID: 0033533741     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1202948     Document Type: Article

References (47)

1. AkiyhamaT, Yoshida T, Tsujita T, Shimizu M, Mizukami T, Okabe M and Akinaga S. (1997). Cancer Res., 57, 1495-1501.
2. Band V, Dala S, Delmolino L and Andropphy EJ. (1993). EMBO J., 12, 1847-1852.
3. Band V, DeCaprio JA, Delmolino L, Kulesa V and Sager R. (1991). J. Virol., 65, 6671-6676.
4. Band V and Sager R. (1989). Proc. Natl. Acad. Sci. USA, 86, 1249-1253.
5. Band V, Zajchowski D, Kulesa V and Sager R. (1990). Proc. Natl. Acad. Sci. USA, 87, 463-467.
6. Berns A. (1994). Curr. Biol., 4, 137-139.
7. Boorne A, Donnelly N and Schrey M. (1998). Breast Cancer Res.Treat., 48, 117-124.
8. Bunch R and Eastman A. (1997). Cell Grow. Diff., 8, 779-788.
9. Carmichael J, Mitchell JB, DeGraff WG, Gamson J, Gazder AF, Johnson BE, Glatstein E and Minna JD. (1988). Br. J. Cancer, 57, 540-547.
10. Courage C, Budworth J and Gescher A. (1995). Br. J. Cancer, 71, 697-704.
11. Dyson N, Guida P, Munger K and Harlow E. (1992). J. Virol., 66, 6893-6902.
12. El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW and Vogelstein B. (1993). Cell, 15, 817-825.
13. Friend S. (1994). Science, 265, 334-335.
14. Gray-Bablin J, Rao S and Keyomarsi K. (1997). Cancer Res., 57, 604-609.
15. Gray-Bablin J, Zalvide J, Fox MP, Knickerbocker CJ, DeCaprio JA and Keyomarsi K. (1996). Proc. Natl. Acad. Sci. USA, 93, 15215-15220.
16. Harbour JW, Lai SL, Whang-Peng J, Gasdar AF, Minna JD and Kaye FJ. (1988). Science, 241, 353-357.
17. Harper JW, Adami GR, Wei N, Keyomarsi K and Elledge SJ. (1993). Cell. 75, 805-816.
18. Harper JW and Elledge SJ. (1996). Curr. Opin. Gene. Dev., 6, 56-64.
19. Hessling JJ, Miller SE and Levy NL. (1980). J. Immunol. Meth., 38, 315-324.
20. Horowitz JM, Park S, Bogenmann E, Cheng J, Yandell DW, Kaye FJ, Minna JD, Dryja TP and Weinberg RA. (1990). Proc. Natl. Acad. Sci., 87, 2775-2779.
21. Iavarone A and Massague J. (1997). Nature, 387, 417-422.
22. Kato J, Matsuoka M, Polyak K, Massague J and Sherr CJ. (1994). Cell, 79, 487-496.
23. Kawakami K, Futami H, Takahara J and Yamaguchi K. (1996). Biochem. Biophys. Res. Comm., 219, 778-783.
24. Keyomarsi K, Conte D, Toyofuku W and Fox MP. (1995). Oncogene, 11, 941-950.
25. Keyomarsi K and Pardee AB. (1993). Proc. Natl. Acad. Sci. USA, 90, 1112-1116.
26. Khleif SN, Degregori J, Yee CL, Otterson GA, Kaye FJ, Nevins JR and Howley PM. (1996). Proc. Natl. Acad. Sci. USA, 93, 4350-4354.
27. LaBaer J, Garrett MD, Stevenson LF, Slingerland J, Sandhu C, Chou HS, Fattaey A and Harlow E. (1997). Genes Dev., 11, 847-862.
28. Meijer L. (1996). Trends Cell Biol., 6, 393-397.
29. Michieli P, Chedid M, Lin D, Pierce JH, Mercer WE and Givol D. (1994). Cancer Res., 54, 3391-3395.
30. Orr MS, Reinhold W, Yu L, Schreiber-Agus N and O'Connor PM. (1998). J. Biol. Chem., 273, 3803-3807.
31. Planas-Silva MD and Weinberg RA. (1997). Mol Cell. Biol., 17, 4059-4069.
32. Pollack IF, Kawecki S and Lazo JS. (1996). J. Neuro., 84, 1024-1032.
33. Polyak K, Kato J.-Y, Soloman MI, Sherr CJ, Masasgue J, Roberts JM and Koff A. (1994). Genes Dev., 8, 9-22.
34. Rao S, Lowe M, Herliczek T and Keyomarsi K. (1998). Oncogene, 17, 2393-2402.
35. Reznikoff CA, Yeager TR, Belair CD, Savelieva E, Puthenveettil JA and Stadler WM. (1996). Cancer Res., 56, 2886-2890.
36. Schnier JB, Nishi K, Goodrich DW and Bradbury EM. (1996). Proc. Natl. Acad. Sci. USA, 93, 5941-5946.
37. Scynaeve C, Stetler-Stevenson M, Sebers S, Kaur G, Sausville E and Worland P. (1993). Cancer Res., 53, 2081-2086.
38. Shao R, Shimizu T and Pommier Y. (1997). Exp. Cell Res., 234, 388-397.
39. Sheikh MS, Li XS, Chen JC, Shao ZM, Ordonez JV and Fontana JA. (1994). Oncogene, 9, 3407-3415.
40. Sherr CJ and Roberts JM. (1995). Genes Dev., 9, 1149-1163.
41. Soule HD, Maloney TM, Wolman SR, Peterson Jr WD, Brenz R, McGrath CM, Russo J, Pauley RJ, Jones RF nd Brooks SC. (1990). Cancer Res., 50, 6075-6086.
42. Takahashi I, Asano K, Kawamoto I, Tamaoki T and Nakano H. (1989). J. Antibiot., 42, 564-570.
43. Takahashi I, Kobayashi E, Asano K, Yoshida M and Nakano H. (1987). J. Antibiot., 40, 1782-1784.
44. Wang Q, Fan S, Eastman A, Worland P, Sausville E and O'Connor P. (1996). J. Nat. Cancer Ins., 88, 956-965.
45. Wang Q, Worland P, Clark J, Carlson B and Sausville E. (1995). Cell Grow. Diff., 6, 927-936.
46. Weinberg RA. (1995). Cell, 81, 323-330.
47. Werness BA, Levine AJ and Howley PM. (1990). Science, 248, 76-79.